The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $77.61

Today's change-0.15 -0.19%
Updated August 23 4:05 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $77.61

Today's change-0.15 -0.19%
Updated August 23 4:05 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp down (U.S.)$0.15

CVS Health Corp closed lower Wednesday, dropping (U.S.)$0.15 or 0.19% to (U.S.)$77.61. Shares have lost 2.07% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 31.97% during the last year.

Key company metrics

  • Open(U.S.) $77.50
  • Previous close(U.S.) $77.76
  • High(U.S.) $77.88
  • Low(U.S.) $77.10
  • Bid / Ask-- / --
  • YTD % change-1.65%
  • Volume3,343,254
  • Average volume (10-day)4,073,979
  • Average volume (1-month)4,661,511
  • Average volume (3-month)5,832,464
  • 52-week range(U.S.) $69.30 to (U.S.) $98.44
  • Beta0.93
  • Trailing P/E15.47×
  • P/E 1 year forward13.23×
  • Forward PEG1.64×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.58%
  • Trailing EPS(U.S.) $5.02
Updated August 23 4:05 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.52%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue45,68544,51445,97144,615
Total other revenue--------
Total revenue45,68544,51445,97144,615
Gross profit6,9356,5807,6067,492
Total cost of revenue38,75037,93438,36537,123
Total operating expense43,56842,72142,97641,899
Selling / general / administrative4,8184,7874,6114,675
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0--0101
Other operating expenses, total--------
Operating income2,1171,7932,9952,716
Interest income (expense), net non-operating-251-258-248-258
Gain (loss) on sale of assets--------
Other--------
Income before tax1,8631,5342,7532,463
Income after tax1,0979621,7071,542
Income tax, total7665721,046921
Net income1,0989521,7071,540
Total adjustments to net income-45-9-6
Net income before extra. items1,0979611,7071,541
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,0939661,6981,535
Inc. avail. to common incl. extra. items1,0949571,6981,534
Diluted net income1,0949571,6981,534
Dilution adjustment--------
Diluted weighted average shares1,0241,0351,0701,073
Diluted EPS excluding extraordinary itemsvalue per share1.070.931.591.43
Dividends per sharevalue per share0.500.500.430.43
Diluted normalized EPSvalue per share1.070.931.591.49